Avinger (AVGR) Set to Announce Earnings on Thursday

Avinger (NASDAQ:AVGRGet Free Report) is scheduled to announce its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($2.03) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Avinger (NASDAQ:AVGRGet Free Report) last posted its quarterly earnings results on Thursday, August 8th. The medical device company reported ($2.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by ($2.39). The company had revenue of $1.85 million during the quarter, compared to analyst estimates of $2.55 million. On average, analysts expect Avinger to post $-5 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Avinger Trading Up 6.2 %

Shares of NASDAQ:AVGR opened at $0.84 on Wednesday. Avinger has a 1-year low of $0.76 and a 1-year high of $5.45. The stock has a market capitalization of $1.93 million, a P/E ratio of -0.07 and a beta of 1.15. The business has a 50-day moving average price of $0.98 and a two-hundred day moving average price of $1.75.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Avinger in a report on Saturday. They issued a “hold” rating on the stock.

Get Our Latest Research Report on AVGR

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Featured Articles

Earnings History for Avinger (NASDAQ:AVGR)

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.